GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (OTCPK:RCDTF) » Definitions » Cyclically Adjusted FCF per Share

Recordati SpA (Recordati SpA) Cyclically Adjusted FCF per Share : $0.94 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Recordati SpA Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Recordati SpA's adjusted free cash flow per share for the three months ended in Dec. 2023 was $0.292. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.94 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Recordati SpA's average Cyclically Adjusted FCF Growth Rate was 1.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Recordati SpA was 25.60% per year. The lowest was 1.20% per year. And the median was 13.30% per year.

As of today (2024-05-17), Recordati SpA's current stock price is $51.60. Recordati SpA's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.94. Recordati SpA's Cyclically Adjusted Price-to-FCF of today is 54.89.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Recordati SpA was 91.17. The lowest was 36.75. And the median was 56.41.


Recordati SpA Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Recordati SpA's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Cyclically Adjusted FCF per Share Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.69 0.85 1.05 0.94

Recordati SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.19 1.03 0.94 -

Competitive Comparison of Recordati SpA's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Recordati SpA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Cyclically Adjusted Price-to-FCF falls into.



Recordati SpA Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Recordati SpA's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.292/119.7000*119.7000
=0.292

Current CPI (Dec. 2023) = 119.7000.

Recordati SpA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.215 99.907 0.258
201406 0.198 100.093 0.237
201409 0.351 99.814 0.421
201412 0.204 99.721 0.245
201503 0.185 99.814 0.222
201506 0.325 100.279 0.388
201509 0.416 100.000 0.498
201512 0.209 99.814 0.251
201603 0.320 99.600 0.385
201606 0.266 99.900 0.319
201609 0.389 100.100 0.465
201612 0.184 100.300 0.220
201703 0.408 101.000 0.484
201706 -1.026 101.100 -1.215
201709 0.196 101.200 0.232
201712 0.161 101.200 0.190
201803 0.412 101.800 0.484
201806 0.432 102.400 0.505
201809 0.523 102.600 0.610
201812 0.176 102.300 0.206
201903 0.248 102.800 0.289
201906 0.159 103.100 0.185
201909 0.537 102.900 0.625
201912 -1.605 102.800 -1.869
202003 0.368 102.900 0.428
202006 0.249 102.900 0.290
202009 0.419 102.300 0.490
202012 0.476 102.600 0.555
202103 0.328 103.700 0.379
202106 0.510 104.200 0.586
202109 0.814 104.900 0.929
202112 0.611 106.600 0.686
202203 0.515 110.400 0.558
202206 0.334 112.500 0.355
202209 0.541 114.200 0.567
202212 0.443 119.000 0.446
202303 0.463 118.800 0.467
202306 0.749 119.700 0.749
202309 -0.965 120.300 -0.960
202312 0.292 119.700 0.292

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Recordati SpA  (OTCPK:RCDTF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Recordati SpA's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=51.60/0.94
=54.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Recordati SpA was 91.17. The lowest was 36.75. And the median was 56.41.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Recordati SpA Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (Recordati SpA) Business Description

Industry
Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (Recordati SpA) Headlines

From GuruFocus

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

By PRNewswire PRNewswire 03-09-2020